Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2022
Janus Henderson adds two directors to its board
Janus Henderson announced that Nelson Peltz and Ed Garden of Trian Partners would join its board as independent non-executive directors, effective 1 February 2022.
2021
PharmEasy closes pre-IPO funding round
PharmEasy closed a pre-IPO funding round worth nearly $350 million. The article reports around $204 million in primary funding and says its parent, API Holdings, also closed a $130–$140 million secondary share sale; the round brought API Holdings’ post-money valuation to $5.6 billion, according to sources.
2021
Centessa raises $250 million Series A
Centessa Pharmaceuticals launched and raised $250 million in an oversubscribed Series A financing led by General Atlantic and co-led by Vida Ventures and Janus Henderson Investors.
2021
HemoShear Therapeutics raises $40 million in Series A financing
HemoShear Therapeutics raised $40 million in a Series A financing led by Suvretta Capital, with Janus Henderson Investors, Adage Capital Management and other private investors participating. The company said the funding would support a phase 2 study of HST5040 and other programs.
2021
Janus Henderson appoints director of institutional solutions in Australia
Janus Henderson appointed Greg Clarke as director of institutional solutions, responsible for linking its Australian institutional business with its marketing and investment divisions.
2020
Apartment List raises $50 million
Rental platform Apartment List raised $50 million in a funding round led by Janus Henderson Investors. The company said it plans to use the funding to increase its sales initiatives and bring renters to its platform.